Geode Capital Management’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Sell |
327,955
-389,569
| -54% | -$425K | ﹤0.01% | 3660 |
|
|
2025
Q1 | $698K | Buy |
717,524
+14,966
| +2% | +$14.6K | ﹤0.01% | 3428 |
|
|
2024
Q4 | $1.04M | Buy |
702,558
+16,569
| +2% | +$24.5K | ﹤0.01% | 3365 |
|
|
2024
Q3 | $1.45M | Buy |
685,989
+40,692
| +6% | +$86.3K | ﹤0.01% | 3224 |
|
|
2024
Q2 | $1.57M | Buy |
645,297
+385,617
| +148% | +$941K | ﹤0.01% | 3177 |
|
|
2024
Q1 | $1.68M | Buy |
259,680
+65,372
| +34% | +$424K | ﹤0.01% | 3180 |
|
|
2023
Q4 | $750K | Buy |
194,308
+20,058
| +12% | +$77.4K | ﹤0.01% | 3458 |
|
|
2023
Q3 | $373K | Buy |
174,250
+8,935
| +5% | +$19.1K | ﹤0.01% | 3717 |
|
|
2023
Q2 | $504K | Buy |
165,315
+35,483
| +27% | +$108K | ﹤0.01% | 3638 |
|
|
2023
Q1 | $338K | Hold |
129,832
| – | – | ﹤0.01% | 3806 |
|
|
2022
Q4 | $266K | Buy |
129,832
+9,545
| +8% | +$19.6K | ﹤0.01% | 3945 |
|
|
2022
Q3 | $542K | Buy |
120,287
+41,007
| +52% | +$185K | ﹤0.01% | 3679 |
|
|
2022
Q2 | $324K | Sell |
79,280
-209,025
| -73% | -$854K | ﹤0.01% | 3990 |
|
|
2022
Q1 | $1.27M | Buy |
288,305
+74,081
| +35% | +$326K | ﹤0.01% | 3502 |
|
|
2021
Q4 | $2.55M | Buy |
214,224
+77,752
| +57% | +$926K | ﹤0.01% | 3258 |
|
|
2021
Q3 | $2.34M | Buy |
136,472
+28,294
| +26% | +$485K | ﹤0.01% | 3280 |
|
|
2021
Q2 | $1.89M | Buy |
+108,178
| New | +$1.89M | ﹤0.01% | 3290 |
|